FDA clears safety test to screen Tysabri patients
(AP) -- The Food and Drug Administration on Friday approved a new diagnostic test to help identify patients who have an increased risk of developing a rare brain infection while taking Biogen Idec's multiple sclerosis drug ...
Jan 20, 2012
0
0